Safety and Immunogenicity of Human Papillomavirus-16/18 AS04-Adjuvanted Vaccine: A Randomized Trial in 10–25-Year-Old HIV-Seronegative African Girls and Young Women

por Sow, Papa Salif, Watson-Jones, Deborah, Kiviat, Nancy, Changalucha, John, Mbaye, Khardiata Diallo, Brown, Joelle, Bousso, Kouro, Kavishe, Bazil, Andreasen, Aura, Toure, Macoumba, Kapiga, Saidi, Mayaud, Philippe, Hayes, Richard, Lebacq, Marie, Herazeh, Marjan, Thomas, Florence, Descamps, Dominique
Publicado 2013

Efficacy, immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine in healthy Chinese women aged 18–25 years: Results from a randomized controlled trial

por Zhu, Feng-Cai, Chen, Wen, Hu, Yue-Mei, Hong, Ying, Li, Juan, Zhang, Xun, Zhang, Yi-Ju, Pan, Qin-Jing, Zhao, Fang-Hui, Yu, Jia-Xi, Zhang, Yan-Shu, Yang, Xiaoping, Zhang, Cheng-Fu, Tang, Haiwen, Zhang, Helen, Lebacq, Marie, David, Marie-Pierre, Datta, Sanjoy K, Struyf, Frank, Bi, Dan, Descamps, Dominique
Publicado 2014